Evaluation of the effect of medication adherence using Pletaal Assist System

Evaluation of the effect of medication adherence using Pletaal Assist System - Evaluation of the effect of medication adherence using Pletaal Assist System

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031148

Enrollment

Registered

2018-02-10

Start date

2018-02-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Use of medication support system (Pletaal Assist System)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 20 years old and over 2) History of non-cardioembolic cerebral infarction, and cilostazol is orally administered for more than 3 months

Exclusion criteria

Exclusion criteria: 1) Patients falling under the cilostazol contraindication 2) Patients who can not understand how to use the Pletaal Assist System due to cognitive dysfunction or brain dysfunction 3) Patients who can not recognize blinking of the lamp of the Pletaal Assist System due to visual disturbance 4) Patients who are incapable of self-management of internal medicine due to motor paralysis or ataxia 5) Other conditions which the physician deems inappropriate.

Design outcomes

Primary

Measure	Time frame
Compliance rate of medication while before, during, and after using Pletaal Assist System.	—

Countries

Japan

Contacts

Public ContactKazumasa Oura

Iwate medical university Department of Internal medicine, Division of Neurology and Gerontology

koura@iwate-med.ac.jp019-651-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026